1. Home
  2. LEE vs CALC Comparison

LEE vs CALC Comparison

Compare LEE & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • CALC
  • Stock Information
  • Founded
  • LEE 1890
  • CALC 2011
  • Country
  • LEE United States
  • CALC United States
  • Employees
  • LEE N/A
  • CALC N/A
  • Industry
  • LEE Newspapers/Magazines
  • CALC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • CALC Health Care
  • Exchange
  • LEE Nasdaq
  • CALC Nasdaq
  • Market Cap
  • LEE 42.1M
  • CALC 48.1M
  • IPO Year
  • LEE N/A
  • CALC N/A
  • Fundamental
  • Price
  • LEE $5.35
  • CALC $3.20
  • Analyst Decision
  • LEE
  • CALC Strong Buy
  • Analyst Count
  • LEE 0
  • CALC 2
  • Target Price
  • LEE N/A
  • CALC $14.50
  • AVG Volume (30 Days)
  • LEE 50.5K
  • CALC 73.7K
  • Earning Date
  • LEE 08-07-2025
  • CALC 11-12-2025
  • Dividend Yield
  • LEE N/A
  • CALC N/A
  • EPS Growth
  • LEE N/A
  • CALC N/A
  • EPS
  • LEE N/A
  • CALC N/A
  • Revenue
  • LEE $581,809,000.00
  • CALC N/A
  • Revenue This Year
  • LEE N/A
  • CALC N/A
  • Revenue Next Year
  • LEE N/A
  • CALC N/A
  • P/E Ratio
  • LEE N/A
  • CALC N/A
  • Revenue Growth
  • LEE N/A
  • CALC N/A
  • 52 Week Low
  • LEE $3.79
  • CALC $1.42
  • 52 Week High
  • LEE $19.63
  • CALC $5.65
  • Technical
  • Relative Strength Index (RSI)
  • LEE 60.67
  • CALC 54.05
  • Support Level
  • LEE $4.26
  • CALC $2.62
  • Resistance Level
  • LEE $6.95
  • CALC $3.73
  • Average True Range (ATR)
  • LEE 0.49
  • CALC 0.35
  • MACD
  • LEE 0.20
  • CALC -0.01
  • Stochastic Oscillator
  • LEE 48.88
  • CALC 52.25

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: